Alivus Life Sciences Limited · Q3FY25
Result on 23 Jan 2025, first traded on 24 Jan 2025; judged on 13 Sep 2026. No read was made before it — it is recorded for the base rate. The company's page →
1 · What the read said
No read. Either the company was not on the calendar in the seven days before the result, or it was excluded that week — the trail below says which.
2 · What the result was
from the filing's XBRLNo reported figures on file for this quarter, so the result itself could not be graded — only the share's reaction was.
3 · What the share did
thirty sessions in, the result day, ten out · from the close before the result- Delivery share
- —
- Volume
- —
- Habit held
- unknown — could not be checked
- Announced
- Fri, after the close — the reaction session is the next day
- Peers reporting
- 0 sector peers reported the same week
4 · Why it went this way
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- No read was made before this result; recorded for the base rate.
A strong or favourable read is right when the share beat the market by more than 2% over ten sessions; weak or unfavourable when it lagged by more. Inside ±2% is flat. Neutral reads make no call.
5 · Every morning's read before it
0 morningsNo morning read was recorded for this result.
6 · Every session in the window
the last stop · each close, and where it stood against the close before the result| Session | Date | Open | High | Low | Close | Day | From base | NIFTY 50 from base |
|---|---|---|---|---|---|---|---|---|
| T-3 | 20 Jan | 1,089.95 | 1,125.00 | 1,064.70 | 1,104.70 | — | -5.33% | +0.60% |
| T-2 | 21 Jan | 1,095.00 | 1,213.70 | 1,095.00 | 1,149.90 | +4.09% | -1.46% | -0.78% |
| T-1 | 22 Jan | 1,129.80 | 1,148.65 | 1,111.05 | 1,122.65 | -2.37% | -3.80% | -0.22% |
| base | 23 Jan | 1,118.00 | 1,219.00 | 1,111.00 | 1,166.95 | +3.95% | +0.00% | +0.00% |
| T+1 | 24 Jan result | 1,200.00 | 1,202.15 | 1,133.30 | 1,149.25 | -1.52% | -1.52% | -0.49% |
| T+2 | 27 Jan | 1,159.10 | 1,213.95 | 1,131.85 | 1,197.50 | +4.20% | +2.62% | -1.62% |
| T+3 | 28 Jan | 1,200.50 | 1,249.90 | 1,121.30 | 1,153.25 | -3.70% | -1.17% | -1.07% |
| T+4 | 29 Jan | 1,160.00 | 1,186.00 | 1,147.05 | 1,156.50 | +0.28% | -0.90% | -0.18% |
| T+5 | 30 Jan | 1,156.50 | 1,177.65 | 1,155.55 | 1,167.00 | +0.91% | +0.00% | +0.19% |
| T+6 | 31 Jan | 1,175.45 | 1,214.40 | 1,175.40 | 1,200.25 | +2.85% | +2.85% | +1.31% |
| T+7 | 3 Feb | 1,155.00 | 1,189.80 | 1,148.75 | 1,176.35 | -1.99% | +0.81% | +0.67% |
| T+8 | 4 Feb | 1,189.00 | 1,220.00 | 1,181.00 | 1,214.95 | +3.28% | +4.11% | +2.30% |
| T+9 | 5 Feb | 1,224.95 | 1,232.00 | 1,201.40 | 1,225.45 | +0.86% | +5.01% | +2.12% |
| T+10 | 6 Feb | 1,232.00 | 1,251.00 | 1,228.40 | 1,237.15 | +0.95% | +6.02% | +1.72% |
| T+11 | 7 Feb | 1,237.15 | 1,247.55 | 1,176.15 | 1,224.55 | -1.02% | +4.94% | +1.53% |
Prices are end-of-day from the exchange, adjusted for corporate actions. "From base" is the move from the close before the result — the same base every number on this page uses. Sessions before the base are the run-up.